CompanyGraph
Tobii Dynavox AB
TDVOX · Nasdaq Stockholm · Sweden
tobiidynavox.comFinancials as of FY2023 · latest on file
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2023 (year ended December 31, 2023). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
10.61BSEK1.12B · vs all stocks (USD)
Trailing P/E
53.70xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.61BSEK170.51M · vs all stocks (USD)
52-Week Change
-41.42%vs all stocks
Market Capitalization
10.61BSEK1.12B · vs all stocks (USD)
Enterprise Value
11.22BSEK1.19B · vs all stocks (USD)
Trailing P/E
53.70xvs Medical Instruments & Supplies peers
Forward P/E
25.82xvs Medical Instruments & Supplies peers
PEG Ratio
0.4773xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
6.58xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
21.44xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.96xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
35.01xvs Medical Instruments & Supplies peers
Gross Margin
68.70%vs Medical Instruments & Supplies peers
Operating Margin
9.82%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.16%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
34.96%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.61BSEK170.51M · vs all stocks (USD)
Revenue per Share (TTM)
15.39SEKUpdated Aug 22, 2026Quarterly Revenue Growth
10.96%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.09BSEK115.67M · vs all stocks (USD)
EBITDA (TTM)
377.60MSEK39.91M · vs all stocks (USD)
Net Income (TTM)
104.10MSEK11.00M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
24.93%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
132.90MSEK14.05M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
104.10MSEK11.00M · vs all stocks (USD)
Revenue
1.61BSEKFY2023 · Dec 31, 2023Cost of Goods Sold
518.90MSEKFY2023 · Dec 31, 2023Gross Profit
1.09BSEKFY2023 · Dec 31, 2023Operating Income
160.30MSEK16.94M · vs all stocks (USD)
Pre-tax Income
119.00MSEKFY2023 · Dec 31, 2023Income Tax Expense
15.00MSEKFY2023 · Dec 31, 2023Net Income
104.10MSEKFY2023 · Dec 31, 2023EBIT
158.40MSEKFY2023 · Dec 31, 2023EBITDA (Income Statement)
320.60MSEKFY2023 · Dec 31, 2023Research & Development
163.50MSEKFY2023 · Dec 31, 2023Selling, General & Administrative
781.20MSEKFY2023 · Dec 31, 2023Other Operating Expenses
200.00KSEKFY2023 · Dec 31, 2023Non-operating Interest Income
1.30MSEKFY2023 · Dec 31, 2023Non-operating Interest Expense
39.40MSEKFY2023 · Dec 31, 2023EPS (Basic)
0.9900SEKFY2023 · Dec 31, 2023EPS (Diluted)
0.9800SEKFY2023 · Dec 31, 2023Basic Shares Outstanding
104.85MSharesFY2023 · Dec 31, 2023Diluted Shares Outstanding
104.85MSharesFY2023 · Dec 31, 2023Preferred Stock Dividends
0.00SEKFY2023 · Dec 31, 2023Operating Cash Flow
132.90MSEKFY2023 · Dec 31, 2023Free Cash Flow
87.40MSEKFY2023 · Dec 31, 2023Cash & Cash Equivalents (End of Period)
161.10MSEKFY2023 · Dec 31, 2023Starting Profit (CF Statement)
119.00MSEKFY2023 · Dec 31, 2023Other Non-cash Items
4.70MSEKFY2023 · Dec 31, 2023Change in Accounts Receivable (CF)
-45.40MSEKFY2023 · Dec 31, 2023Change in Other Assets/Liabilities
54.60MSEKFY2023 · Dec 31, 2023Capital Expenditures
-45.50MSEKFY2023 · Dec 31, 2023Net Intangibles (CF)
-89.00MSEKFY2023 · Dec 31, 2023Net Acquisitions
-164.40MSEKFY2023 · Dec 31, 2023Other Investing Activity
2.00MSEKFY2023 · Dec 31, 2023Net Investing Cash Flow
-207.90MSEKFY2023 · Dec 31, 2023Long-term Debt Issuance
99.00MSEKFY2023 · Dec 31, 2023Other Financing Charges
-200.00KSEKFY2023 · Dec 31, 2023Net Financing Cash Flow
98.80MSEKFY2023 · Dec 31, 2023Shares Outstanding
104.85MSharesUpdated Aug 22, 2026Total Cash (MRQ)
0.00SEKvs all stocks (USD)
Total Debt (MRQ)
710.00MSEK75.04M · vs all stocks (USD)
Current Ratio (MRQ)
1.19xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
3.50SEKUpdated Aug 22, 2026Total Assets
1.69BSEK178.58M · vs all stocks (USD)
Total Current Assets
633.40MSEKFY2023 · Dec 31, 2023Total Liabilities
1.39BSEKFY2023 · Dec 31, 2023Total Non-current Assets
1.06BSEKFY2023 · Dec 31, 2023Total Non-current Liabilities
853.10MSEKFY2023 · Dec 31, 2023Total Current Liabilities
538.80MSEKFY2023 · Dec 31, 2023Cash
160.60MSEKFY2023 · Dec 31, 2023Cash Equivalents
500.00KSEKFY2023 · Dec 31, 2023Cash & Cash Equivalents
161.10MSEKFY2023 · Dec 31, 2023Accounts Receivable
270.00MSEKFY2023 · Dec 31, 2023Inventory
129.30MSEKFY2023 · Dec 31, 2023Accounts Payable
100.50MSEKFY2023 · Dec 31, 2023Short-term Debt
83.80MSEKFY2023 · Dec 31, 2023Other Current Liabilities
69.30MSEKFY2023 · Dec 31, 2023Long-term Debt
689.50MSEKFY2023 · Dec 31, 2023Other Non-current Liabilities
141.70MSEKFY2023 · Dec 31, 2023Common Stock (Book)
500.00KSEKFY2023 · Dec 31, 2023Retained Earnings
299.80MSEKFY2023 · Dec 31, 2023Total Shareholders' Equity
297.80MSEK31.47M · vs all stocks (USD)
52-Week Low
57.20SEKUpdated Aug 22, 202652-Week High
131.70SEKUpdated Aug 22, 202652-Week Change
-41.42%vs all stocks
50-Day MA
0.00SEKUpdated Aug 22, 2026200-Day MA
0.00SEKUpdated Aug 22, 2026Avg 10-Day Volume
242.80KSharesUpdated Aug 22, 2026Avg 30-Day Volume
355.10KSharesUpdated Aug 22, 2026Diluted EPS (TTM)
0.9800SEKUpdated Aug 22, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Nutex Health Inc.
Tier 1ProductionThroughput-Bound ConversionRuleInterface
Shenzhen AV-Display Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hd Hyundai Energy Solutions Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Suzhou Shijia Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Zhejiang Asia-Pacific Mechanical & Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kingsignal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
U.S. Physical Therapy Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangsu Seagull Cooling Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Longwell Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Foshan Electrical and Lighting Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Avery Dennison Corporation
4 interpretationsIndustry-Benchmarked Return on Capital ElevatedElevated ROE With High Debt-to-Equity and Equity MultiplierReceivables Heavy and GrowingElevated Leverage on Three Denominators
Cencora Inc.
4 interpretationsIndustry-Benchmarked Return on Capital ElevatedElevated ROE With High Debt-to-Equity and Equity MultiplierReceivables Heavy and GrowingElevated Leverage on Three Denominators
Acadian Asset Management Inc.
4 interpretationsIndustry-Benchmarked Return on Capital ElevatedElevated ROE With High Debt-to-Equity and Equity MultiplierReceivables Heavy and GrowingElevated Leverage on Three Denominators